Next report date
Report period
H1 2024
EPS estimate
—
Revenue estimate
—
0.16EUR
124.27 MEUR
578.91 MEUR
254.51 M
About CHINA SHINEWAY PHARMACEUTICAL GR
Sector
Headquarters
Shijiazhuang
Employees (FY)
3.44 K
Website
Founded
2002
FIGI
BBG000QZH4K4
China Shineway Pharmaceutical Group Ltd. is an investment holding company, which engages in the research and development, manufacturing, and trading of Chinese pharmaceutical products. Its products include Shen Mai injection, Qing Kai Ling injection, and Wu Fu Xin Nao Qing soft capsule. The company was founded by Zhen Jiang Li and Yun Xia Xin on August 14, 2002 and is headquartered in Shijiazhuang, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange CHINA SHINEWAY PHAR.HD-10 stocks are traded under the ticker C1S.
CHINA SHINEWAY PHAR.HD-10 is going to release the next earnings report on Aug 30, 2024. Keep track of upcoming events with our Earnings Calendar.
CHINA SHINEWAY PHAR.HD-10 revenue for the last quarter amounts to 303.17 M EUR despite the estimated figure of 299.29 M EUR. In the next quarter revenue is expected to reach 288.02 M EUR.
Yes, you can track CHINA SHINEWAY PHAR.HD-10 financials in yearly and quarterly reports right on TradingView.
C1S net income for the last quarter is 59.91 M EUR, while the quarter before that showed 65.01 M EUR of net income which accounts for −7.85% change. Track more CHINA SHINEWAY PHAR.HD-10 financial stats to get the full picture.
Like other stocks, C1S shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CHINA SHINEWAY PHAR.HD-10 stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 29, 2024, the company has 3.44 K employees. See our rating of the largest employees — is CHINA SHINEWAY PHAR.HD-10 on this list?
We've gathered analysts' opinions on CHINA SHINEWAY PHAR.HD-10 future price: according to them, C1S price has a max estimate of 2.14 EUR and a min estimate of 1.43 EUR. Read a more detailed CHINA SHINEWAY PHAR.HD-10 forecast: see what analysts think of CHINA SHINEWAY PHAR.HD-10 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CHINA SHINEWAY PHAR.HD-10 EBITDA is 147.71 M EUR, and current EBITDA margin is 22.81%. See more stats in CHINA SHINEWAY PHAR.HD-10 financial statements.